Portfolio Cross-Sell Leverage Bio-Techne's branded portfolios (R&D Systems, Spatial, Diagnostics) to engage researchers with end-to-end solutions across reagents, imaging, and clinical diagnostics. Target growth areas such as cancer research, neuroscience, diabetes, and rare diseases, and offer multi-brand bundles that simplify procurement and accelerate timelines.

Advanced Characterization Capitalize on the new integrated icIEF fractionation with mass photometry workflow announced with Refeyn to offer bundled instrumentation, reagents, and services. Target teams working on bispecific antibodies and biosimilars who need rapid, single-molecule resolution characterization to reduce development risk.

Global Expansion Bio-Techne's global footprint and sizable employee base enable scalable sales and service to multinational biopharma and contract research organizations. Identify regional opportunities to expand direct field coverage, accelerate installation, and strengthen local support and regulatory compliance.

Data Driven Selling Strong CRM and analytics capabilities indicated by Salesforce Marketing Cloud, Tableau, and other tools can power account-based marketing and personalized outreach. Use digital and field activities to target biotech clusters, universities, and hospitals with tailored bundles and proof-of-value demonstrations.

Strategic Partnerships The collaboration with Refeyn highlights a model for strategic partnerships; explore similar co-development, licensing, or OEM opportunities with imaging, analytics, or diagnostics technology partners to access new customer segments and shorten the sales cycle. Propose joint pilots with leading biopharma and CROs.